主要文件

查看所有文档

F2756

荧光素二(β-D-吡喃半乳糖苷)

Name: 荧光素二(β-<SC>D</SC>-吡喃半乳糖苷)
Brand: SIGMA

别名:

FDG

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₃₂H₃₂O₁₅

化学文摘社编号:

17817-20-8

分子量:

656.59

NACRES:

NC.07

PubChem Substance ID:

24894829

UNSPSC Code:

12352201

MDL number:

MFCD00077344

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

assay

≥98% (HPLC)

Quality Level

100

form

powder

solubility

methanol: 20 mg/mL, clear, yellow

storage temp.

−20°C

SMILES string

OC[C@H]1O[C@@H](Oc2ccc3c(Oc4cc(O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)ccc4C36OC(=O)c7ccccc67)c2)[C@H](O)[C@@H](O)[C@H]1O

InChI

1S/C32H32O15/c33-11-21-23(35)25(37)27(39)30(45-21)42-13-5-7-17-19(9-13)44-20-10-14(43-31-28(40)26(38)24(36)22(12-34)46-31)6-8-18(20)32(17)16-4-2-1-3-15(16)29(41)47-32/h1-10,21-28,30-31,33-40H,11-12H2/t21-,22-,23+,24+,25+,26+,27-,28-,30-,31-/m1/s1

InChI key

ZTOBILYWTYHOJB-WBCGDKOGSA-N

说明

General description

β-半乳糖苷酶的荧光底物

Application

荧光素二(β-D-吡喃半乳糖苷)已用作β-半乳糖苷酶试验中的底物。

荧光素二(β-D-吡喃半乳糖苷)（FDG）已可用于通过FACS（荧光激活细胞分选）检测基因表达。

Biochem/physiol Actions

荧光素二(β-D-吡喃半乳糖苷)(FDG被β-半乳糖苷酶水解成荧光素后发出荧光。它能产生与酶活性成比例的荧光。当使用β-半乳糖苷酶（Lac Z）作为报告基因时，该分子主要用于检测转染细胞中的基因表达。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

涉药品监管产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Timing controllable electrofusion device for aqueous droplet-based microreactors.

Wei-Heong Tan et al.

Lab on a chip, 6(6), 757-763 (2006-06-02)

This paper describes an electrofusion device for controlling the precise moment of fusion between droplets by applying an electric field. This device allows (i) accurate determination of the start of chemical/biological reactions, (ii) minimum contact of reactants with channel walls--eliminating

Positive association between cerebral grey matter metabolism and dopamine D2/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study.

Serge A Mitelman et al.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 21(5), 368-382 (2019-09-26)

Objectives: Overlapping decreases in extrastriatal dopamine D2/D3-receptor availability and glucose metabolism have been reported in subjects with schizophrenia. It remains unknown whether these findings are physiologically related or coincidental.Methods: To ascertain this, we used two consecutive 18F-fluorodeoxyglucose and 18F-fallypride positron

Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.

Shotaro Naganawa et al.

Medicine, 96(46), e8832-e8832 (2017-11-18)

Although delayed-time-point imaging is expected to improve the results of [F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT), how examinees will benefit from dual-time-point imaging versus initial-time-point imaging alone, remains unclear. This study investigated the role of delayed-time-point imaging in improving the

查看所有相关文献

全球贸易项目编号

货号	GTIN
F2756-1MG	04061833613009
F2756-25MG	04061833613269
F2756-5MG	04061833613290